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I. Abstract
Magnetic nanoparticles are tiny magnets of the size of large molecules. These 
nanoparticles can be used as markers for biomedical analysis with remarkable 
properties. By homogenous magnetic fields they can be rotated and by gradient 
fields they can be steered with magnetic forces. By antibody functionalization 
of their surface other proteins can be coupled to the nanoparticles. This way the 
mobility of the nanoparticle is changed, which can be detected macroscopically 
by the modified response to external magnetic fields. Protein interaction can 
help to deliver drugs and to localize infections or inflammations for diagnostic 
or therapeutic purposes by magnetic particle imaging (MPI).                                       
II. Introduction
The human immune system is almost perfect. By far the most infections are 
handled without us even noticing it. On our body surface live more bacteria than 
we have cells in the body. Our bacteria on the inner and outer surfaces of our 
body amount to more than 1 kg. But within the blood of a healthy human one 
can find not a single bacterium, since our immune system is our best protection. 
So we need drugs to support the immune system and in future these drugs should 
find their targets by themselves.
Magnetic nanoparticles are quite perfect carriers for this purpose in the blood-
stream. Their size of 10–30 nm can be as small as a larger protein molecule 
(hemoglobin 6 nm) and so they can pass all capillary vessels. They can transport 
drugs everywhere in the body. By functionalization with appropriate antibody 
molecules they even find their targets themselves, be it bacterial or viral surface 
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proteins. Additionally, they can even be steered by a magnetic gradient field 
towards a tumor site. After several passages of the liver, iron-oxide magnetic 
nanoparticles are metabolized in the human body without problems if their con-
centration is low enough.
For successful and reliable operation the magnetic nanoparticles have to be 
throughout characterized, regarding composition, size, form, stabilization, 
magnetic and chemical properties. During storage these properties should not 
change. These requirements today are only partly fulfilled. In the chemical prep-
aration process of magnetic nanoparticles it still is almost impossible to produce 
exactly the same nanoparticles in every batch. During storage, agglomeration 
and sedimentation can occur and the stabilizing shell for good dispersion and for 
functionalization can be degrading gradually. Thus, characterization has to con-
trol quality and properties again at bedside before application. Here, the methods 
for a comprehensive quality control of magnetic nanoparticles are reviewed and 
biomedical applications for magnetic nanoparticles are presented.
III. Properties of magnetic nanoparticles
The toxicity of magnetic nanoparticles depends strongly on their core material. 
Iron-oxide nanoparticles are regarded mainly as non-toxic, but discussions on 
differences regarding their iron oxidation state still continue. Nanoparticles can 
be produced as single core or as multicore particles as depicted in Fig.1. 
The first analysis has to ensure that the material composition of the magnetic 
nanoparticles for biomedical applications excludes cobalt or nickel traces, which 
should not be applied to mammals, since these metals cannot be metabolized. 
The second and third step are the determination of the size distribution and the 
Fig. 1 Nanoparticles
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concentration of magnetic nanoparticles, which are closely related. To get inde-
pendent measures one often determines the size distribution, but the concentra-
tion is analyzed as equivalent iron atoms per volume of water solvent without 
taking the size distribution into account. The determination of the size distribu-
tion is often complicated by agglomeration and cluster formation. In reality, the 
dispersed nanoparticles can consist of a broad size distribution. So the charac-
terization has to distinguish the thermal distribution governed by the Langevin 
equation for the thermal activation of the magnetic moment, the core size distri-
bution, the shell thickness distribution, and the distribution of the shell function-
alization. Thus a traceable characterization of size distribution, concentration, 
and particle properties with measurement uncertainties still is an important me-
trology task for the next years.
The magnetic properties of magnetic nanoparticles strongly depend on the size, 
as depicted in Fig. 2. In general, magnetic material exhibits magnetization char-
acteristics as depicted in Fig. 2(a).  The hysteresis loop is characterized by a co-
ercive field Hc, which depends on the material (hard/soft magnet) by its domain 
wall pinning properties.  The saturation magnetization Ms is reached for high ex-
ternal magnetic fields. In the case of hard magnets the material stays magnetized 
with the remanent magnetization Mr, even if the external magnetic field is re-
duced to zero. Large magnetic microparticles are found in a multidomain (MD) 
state. If the size of the magnet shrinks, the coercive field Hc shows a maximum, 
if only one domain wall can exist in the particle. For even smaller size the single 
domain (SD) nanoparticles loose their coercivity and ferromagnetic behavior 
and enter the region of superparamagnetism (SP). Here, a macroscopic mag-
netic moment is only established in external magnetic fields and no coercivity is 
found anymore. The still existing magnetic moment of a single nanoparticle is 
not aligned by crystalline or surface anisotropy in the material anymore. 
Fig. 2 (a) Dependence of the magnetization on the external magnetic field, (b) dependence 
of the coercivity on the nanoparticle core diameter. 
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The magnetic moment m of a nanoparticle is proportional to the saturation mag-
netization Ms and its core volume Vc. 
m = MsVC          
The saturation magnetization Ms depends on the material of the core. If the 
material properties are well known, the volume distribution is traceable to the 
distribution of the magnetic moments m. Thus, it is possible, to measure the size 
distribution magnetically.
In the following only superparamagnetic particles are considered, since they are 
small enough for biomedical applications in the human body. To measure the 
magnetic moment distribution the thermal influence expressed by the Langevin 
function has to be taken into account. Many superparamagnetic moments are not 
aligned in moderate external magnetic field due to their Brownian motion in the 
liquid environment of a solvent, most often water. But even immobilized super-
paramagnetic nanoparticles are not aligned in the moderate magnetic field, but 
can orient in other directions by the internal degree of freedom, the Néel relax-
ation. Only rather high external magnetic fields can orient all moments of super-
paramagnetic nanoparticles into the saturated state. The total energy of the mag-
netic moment m of an superparamagnetic nanoparticle can be described by [1]
Eges = KV sin2 Θ – mBcos (Θ – Φ)
                                                                          Internal anisotropy                   External field
The first term describes the internal anisotropy energy by its anisotropy constant 
K, the core volume Vc taking into account the angle Θ between its anisotropy 
axis and the direction of the external magnetic field. The second term describes 
the energy of the magnetic moment m in the external flux density B taking into 
account additionally the angle Φ of the magnetization with respect to the anisot-
ropy axis. For both relaxation mechanisms, Brownian and Nèel relaxation, the 
energy landscapes are depicted in Fig. 3 with and without external magnetic flux 
density B. For the description of dispersed nanoparticles all energy contributions 
of all thermally distributed nanoparticles by the Langevin function have to be 
integrated over both angles Θ and Φ . 
IV. Methods for the characterization of magnetic nanoparticles
Many methods can be applied to characterize magnetic nanoparticles. Due to 
their small size optical microscopy cannot contribute. Instead scanning electron 
microscopy SEM and transmission electron microscopy TEM are employed to-
gether with scanning probe microscopy AFM and MFM. The crystalline proper-
ties are analyzed by x-ray diffraction XRD. The hydrodynamic size distribution 
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can be investigated by dynamic light scattering DLS and photon (cross) corre-
lation spectrometry P(C)CS. The magnetic properties are determined by static 
magnetization measurements M(H) in a SQUID magnetometer. The dynamic 
magnetic properties are measured by ac susceptibility measurements ACS, in 
the magnetization and the magnetic relaxation MRX, magnetic particle spectros-
copy MPS and in rotating magnetic fields RMF.  All these methods are grouped 
together in Fig. 4. The main challenge is to obtain a consistent data set of all 
methods applied to a nanoparticle sample. 
In several projects we developed novel instruments for the fast and precise 
characterization of magnetic nanoparticles. Such an instrument is the Magnetic 
Nanoparticle Relaxation Analyzer shown in Fig. 5, which was evaluated togeth-
er with Merck KGaA, Darmstadt.
Many different procedures and recipes exist for the growth of magnetic nanopar-
ticles in solution, i.e. co-precipitation, hydrothermal synthesis, microemulsion 
and thermal decomposition of iron oleate. The latter has been employed suc-
cessfully in the institute and the resulting nanoparticles proved to be very well 
reproducible [3]. These particles have been analyzed in detail by high resolution 
transmission electron microscopy, as depicted in Fig. 6. The inner core consists 
mainly of wustite FeO, while in the outer core area Fe3O4 (magnetite) is found. 
For maximum saturation magnetization the oxidation process during growth of 
the nanoparticles has to be carefully optimized to avoid the occurrence of such 
oxygen deficient phases.
Fig. 3. Dependence of the energy distributions in Brownian and Néel relaxation with and 
without external magnetic field.
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The dynamic magnetic properties are analyzed by ac susceptibility measure-
ments (ACS) on dispersed nanoparticles and on immobilized samples from 
the same batch. Immobilization is easily accomplished by freeze drying. In ac 
susceptibility the reaction of the nanoparticles to time-dependent sinusoidal ex-
ternal magnetic fields is recorded and analyzed. Typical ac susceptibility mea-
surements for multicore magnetic nanoparticles of different hydrodynamic size 
(increasing from FeraSpin XS to XXL) are depicted in Fig. 7. FeraSpin R par-
ticles contain a broad size distribution.
The analysis of the static M(H) SQUID magnetometer data requires a mathe-
matical model and by assuming a bimodal distribution f(m) the magnetization 
M(H) can be described by [4]:
Fig. 4 Methods for the characterization of magnetic nanoparticles.
Fig. 5 MRX analyzer with coil system of high homogeneity and minimum stray field and 
a simple user interface with touch screen [2].
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Fig. 6 Transmission electron microscopy of magnetic nanoparticles. (a)image, (b) diffraction 
analysis SEAD, (c,d) evaluation of lattice con-stants, (e,f) analysis of different crystalline 
phases in the core (FeO) and Fe3O4 in the outer core volume [3].The HRTEM measurements 
were taken in cooperation with H. Weller et al., Univ. Hamburg
Fig. 7. AC susceptibility measurements in small signal mode (Bac= 95 µT in frequency 
range from 100 Hz - 1 MHz).
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By applying a SVD algorithm [5] we verified for this model the size distribution 
parameters according to Fig. 8.
For larger nanoparticle diameter ac susceptibility measurements become rather 
time consuming, since the characteristic time constants are longer for larger 
particles. For such particles the measurement of the magnetic relaxation MRX 
is more convenient. First, the particles are magnetized in an external magnetic 
field, then the field is switched off and the relaxation of the nanoparticle magne-
tization is determined by magnetic sensors.  In our set-up we use either fluxgate 
sensors [6] or dc-SQUID sensors [7].
The recorded MRX data of the immobilized nanoparticles are shown in Fig. 
9. In such measurements the  contributions of larger particles can be easily de-
tected, since the contributing frequency range can be extended to much lower 
frequencies than 100 Hz. The model for the measured magnetic moment mr 
in the relaxation process assumes non-interacting nanoparticles. It has to take 
into account the time for magnetization tmag, which determines the number of 
aligned moments in the external magnetic field H prior to the relaxation with 
respect to the Néel relaxation time tNH in the magnetizing field H. The Langevin 
function L(d,H,T) determines the influence of temperature T on the alignment of 
nanoparticles with diameter d. The relaxation is governed by the Néel relaxation 
time tN without external field. The size distribution f (lognormal distribution) has 
to be taken into account as well and can be obtained from these measurements by 
inverting the model equation [8]:
Fig. 8: Size distributions of magnetic nanoparticles  with different hydrodynamic diameters.
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One theoretical relaxation curve is added to Fig. 9 as the dashed line for a bi-
modal distribution. In samples where both Brownian and Néel relaxation take 
place at the same time the faster relaxation governs the experimental observed 
effective relaxation time as depicted in Fig. 10 with                                              
and                   [9].
Fig. 9 MRX measurements on the same magnetic nanoparticles as in Fig. 8.
Fig. 10 Observed effective relaxation time in MRX measurements
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The ACS and MRX measurements allow to determine the size distributions of 
magnetic nanoparticles dispersed in solution. So far water was assumed as sol-
vent. But these methods can be extended to investigate nanoparticle interaction 
with the surrounding matrix characterized by the observed nanoviscosity, as de-
picted in Fig. 11 for CoFe2O4 nanoparticles (dc = 15 nm)  with 2.5 wt% aqueous 
gelatin solution together with a MRX-simulation with parameters from fits to 
ACS spectra [10]. 
In table 1 the possibilities to analyze and to manipulate magnetic nanoparticles 
by magnetic fields are summarized.
Table 1: Possibilities to analyze and manipulate magnetic nanoparticles.
Fig. 11. Determination of the nanoviscosity of  gelatine after heating and fast cooling to 
23 °C from the MRX measurements during gelation.
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V. Medical applications of magnetic nanoparticles
The biomedical application areas of magnetic nanoparticles are widespread. The 
nanoparticles can be used as markers in immunoassays and in binding-assays 
like in biochips based on DNA or RNA detection.  They are often used as mag-
netic beads for separation of proteins. The demonstrated micro- and nanovis-
cosity measurements are used to characterize gel formation and dissolution as 
required for drug delivery. Functionalized nanoparticles can themselves carry 
drugs and be steered by external fields to the application site inside the body. 
The absorption of ac magnetic fields can be used to locally heat the volume 
around the nanoparticles in hyperthermia to drive tumor cells into apoptosis. For 
every mentioned application nanoparticles with special magnetic properties are 
required and for in-vivo applications long term stable nanoparticles without ag-
glomeration or sedimentation are required.
A very powerful new medical imaging modality is the so called magnetic particle 
imaging MPI, which was invented by Gleich and Weizenecker [11] at Philips, 
Hamburg in 2005. Their idea was to create a point in space where the magnetic 
field vanishes. This can easily be accomplished by two planar coils with antipar-
allel orientation. Due to their combined, opposite dipole fields exactly one point 
in space is field free. This point can be scanned through the volume of inter-
est by superimposed homogeneous magnetic fields from additional drive field 
coils in all orthogonal directions without any moving parts. If there are magnetic 
nanoparticles inside this volume of interest, they are exposed to a time varying 
magnetic field during the scanning process. Due to their nonlinear magnetization 
curve the nanoparticles produce different higher harmonics for certain positions 
of the field free point. This way the positions of the magnetic nanoparticles can 
be spatially decoded by the fast motion of the field free point in space and an 
appropriate reconstruction method. Even in the early publications already 30 
images per second were demonstrated with the prospect of a simple and fast 
magnetic imaging modality using magnetic nanoparticles as contrast agent. One 
drawback are the high gradient fields occurring in this process, which might 
move the particles, and the high frequency fields, which might heat the tissue 
too much beyond the ICNIRP acceptable limits. The first MPI system built com-
pletely in the institute at TU Braunschweig is depicted in Fig. 12 [12].
The generation of higher harmonics by the magnetic nanoparticles is visualized 
in Fig. 13. Depending on the superimposed selection field the sinusoidal drive 
field has a different offset and produces the spectral fingerprint shown at the right 
columns. 
The simulated odd harmonic spectra for one dimensional positions of the field 
free point symmetrically around a position at 25 units are shown in Fig. 14. For 
a high resolution imaging many harmonics have to be recorded, as first approxi-
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Fig. 12. MPI equipment and MPI coil assembly in the EMG-institute at TU Braunschweig.
Fig. 13 Creation of higher harmonics of a sinusoidal excitation of the magnetization of 
magnetic nanoparticles.
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mation the number of harmonics gives the number of pixels in one dimension. 
To encode the three-dimensional space, three slightly frequency shifted sinusoi-
dal drive fields are employed, resulting in a three-dimensional Lissajous trace of 
the field free point to cover the whole volume of interest. The signature of the 
harmonic content, as recorded in the system matrix by calibration measurements 
before, is used by the reconstruction algorithm to image the unknown spatial 
nanoparticle distribution. At least three different approaches for reconstruction 
are pursued, as summarized in table 2. The simplest, but slowest method is to 
Fig. 14 Harmonic spectra for different positions of the field free point with respect to the 
nanoparticles.
Table 2. Different approaches for reconstruction in MPI.
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analyze only single harmonics at a time with the advantage that a narrow band 
high-sensitivity receiver set-up can be employed. If many harmonics are re-
corded simultaneously a large bandwidth receiver is required with higher noise 
contribution and higher susceptibility to all kinds of external noise sources. 
The similar x-space reconstruction uses the time domain signals for recon-
struction, but is considerably slower. So, for fast imaging the frequency do-
main reconstruction is preferable, despite is higher complexity [13].
VI. Conclusions and Outlook
Magnetic nanoparticles are characterized by their size dependent magnetic 
properties. Depending on the material they behave superparamagnetic for the 
size required in biomagnetic applications in the human body. For a safe and 
reproducible application the magnetic nanoparticles have to be characterized 
throughout. Quality control requires to stabilize these properties from the pro-
duction to the final application in diagnosis or therapy. This is still a consider-
able task to achieve. For diagnosis magnetic nanoparticles can be employed as 
markers in Magnetic Particle Imaging MPI. This new method provides unique 
imaging perspectives, as quantitative marker based molecular imaging of func-
tion with an affordable imaging system. The markers are biocompatible and 
long-term stable. Bound and unbound particles can be distinguished by their 
magnetic behavior. With MPI fast imaging of 46 pics/s or 21,5 ms for full field 
of view are already demonstrated [14]. MPI is sensitive imaging, since as low 
as 100 nmol Fe are detectable in immunoassays. MPI can be combined with 
other imaging methods for anatomy as fluorescence superresolution micros-
copy by fluorescent magnetic nanoparticles, but MRI, CT and PET are also 
possible.
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